About
Our Science
Our Programs
Careers
Investors & Media
Stockholder Tools
Global - Contact
Investor Contact
Kia Khalaghpour, Ph.D.
Vice President, Investor Relations and Communications
Constellation Pharmaceuticals
+1-617-844-6859
kia.khaleghpour@constellationpharma.com
Media Contact
Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com
SEC Filings
Filing date | Form | Description | Filing Group | View |
---|---|---|---|---|
10-Q | Quarterly report which provides a continuing view of a company's financial position |
Quarterly Filings
|
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
3 | Initial filing by director officer or owner of more than ten percent. |
3,4,5
|
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML | |
SC 13G/A | An amendment to the SC 13G filing |
Other
|
View HTML | |
424B5 | Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
Registration Statements
|
View HTML | |
8-K | Report of unscheduled material events or corporate event |
Current Reports
|
View HTML | |
8-K | Report of unscheduled material events or corporate event |
Current Reports
|
View HTML | |
424B5 | Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
Registration Statements
|
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML | |
8-K | Report of unscheduled material events or corporate event |
Current Reports
|
View HTML |
Data provided by Kaleidoscope.
Investors & Media
About
Our Science
Our Programs
Careers
Investors & Media
Stockholder Tools
Investor Contact
Kia Khalaghpour, Ph.D.
Vice President, Investor Relations and Communications
Constellation Pharmaceuticals
+1-617-844-6859
kia.khaleghpour@constellationpharma.com
Media Contact
Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com